Gene · 3802
Papers2,190
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,190
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioactive Constituents of Verbena officinalis Alleviate Inflammation and Enhance Killing Efficiency of Natural Killer Cells. | Int J Mol Sci | 2023 | 37108306 | PubTator, text mining | PubMed |
| Identification of natural killer cell associated subtyping and gene signature to predict prognosis and drug sensitivity of lung adenocarcinoma. | Front Genet | 2023 | 37091780 | PubTator, text mining | PubMed |
| Impact of high human genetic diversity in Africa on immunogenicity and efficacy of RTS,S/AS01 vaccine. | Immunogenetics | 2023 | 37084013 | PubTator, text mining | PubMed |
| KIR-HLA interactions extend human CD8+ T cell lifespan in vivo. | J Clin Invest | 2023 | 37071474 | PubTator, text mining | PubMed |
| Relative expression of receptors in uterine natural killer cells compared to peripheral blood natural killer cells. | Front Immunol | 2023 | 37051244 | PubTator, text mining | PubMed |
| Presence of KIR2DL2/S2, KIR2DL5, and KIR3DL1 Molecules in Liver Transplant Recipients with Alcoholic Cirrhosis Could Be Implicated in Death by Graft Failure. | Diagnostics (Basel) | 2023 | 37046435 | PubTator, text mining | PubMed |
| Influence of killer immunoglobulin-like receptors genes on the recurrence rate of ocular toxoplasmosis in Brazil. | Mem Inst Oswaldo Cruz | 2023 | 37018796 | PubTator, text mining | PubMed |
| Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation. | Front Immunol | 2023 | 37006317 | PubTator, text mining | PubMed |
| AVPR2 is a potential prognostic biomarker and correlated with immune infiltration in head and neck squamous cell carcinoma. | BMC Med Genomics | 2023 | 36998036 | PubTator, text mining | PubMed |
| Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging. | Pharmaceutics | 2023 | 36986778 | PubTator, text mining | PubMed |
| Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis. | Cancers (Basel) | 2023 | 36980671 | PubTator, text mining | PubMed |
| HERVs and Cancer-A Comprehensive Review of the Relationship of Human Endogenous Retroviruses and Human Cancers. | Biomedicines | 2023 | 36979914 | PubTator, text mining | PubMed |
| ADCY7 mRNA Is a Novel Biomarker in HPV Infection and Cervical High-Grade Squamous Lesions or Higher. | Biomedicines | 2023 | 36979847 | PubTator, text mining | PubMed |
| Study of the shared gene signatures of polyarticular juvenile idiopathic arthritis and autoimmune uveitis. | Front Immunol | 2023 | 36969183 | PubTator, text mining | PubMed |
| Platelet, a key regulator of innate and adaptive immunity. | Front Med (Lausanne) | 2023 | 36968817 | PubTator, text mining | PubMed |
Combined flow cytometry natural killer immunophenotyping and KIR/HLA-C genotyping reveal remarkable differences in acute myeloid leukemia patients, but suggest an overall impairment of the natural killer response. | Front Med (Lausanne) | 2023 | 36960339 | PubTator, text mining | PubMed |
| Diversity of immune checkpoints in cancer immunotherapy. | Front Immunol | 2023 | 36960057 | PubTator, text mining | PubMed |
| Comparison of NK alloreactivity prediction models based on KIR-MHC interactions in haematopoietic stem cell transplantation. | Front Immunol | 2023 | 36936953 | PubTator, text mining | PubMed |
| Natural killer cells in COVID-19: from infection, to vaccination and therapy. | Future Virol | 2023 | 36936055 | PubTator, text mining | PubMed |
| Roles of N-linked glycosylation and glycan-binding proteins in placentation: trophoblast infiltration, immunomodulation, angiogenesis, and pathophysiology. | Biochem Soc Trans | 2023 | 36929183 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3802/papers?page=10